EUVIMEDEUVIMED entdecken
Crossref

Ultrasensitive CCL2 Detection in Urine for Diabetic Nephropathy Diagnosis Using a WS 2 -Based Plasmonic Biosensor

Shuangshuang Gao, Huili Li, Lixuan Liu, Yiming Tian, Rui Wang, Xuanlin Pan, Fusheng Wen iD, Jianyong Xiang iD, Anmin Nie, Kun Zhai iD, Bochong Wang, Congpu Mu iD und 2 weitere

Nano Letters · 2024

DOI: 10.1021/acs.nanolett.4c00981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2024. Verfasst von Shuangshuang Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for High Pressure Science, State Key Lab of Metastable Materials Science and Technology, Yanshan University, Qinhuangdao 066004, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Biosensing Techniques, Chemokine CCL2, Biomarkers. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Department of Education of Hebei Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accurate diagnosis of diabetic nephropathy relies on achieving ultrasensitive biosensing for biomarker detection. However, existing biosensors face challenges such as poor sensitivity, complexity, time-consuming procedures, and high assay costs. To address these limitations, we report a WS2-based plasmonic biosensor for the ultrasensitive detection of biomarker candidates in clinical human urine samples associated with diabetic nephropathy. Leveraging plasmonic-based electrochemical impedance microscopy (P-EIM) imaging, we observed a remarkable charge sensitivity in monolayer WS2 single crystals. Our biosensor exhibits an exceptionally low detection limit (0.201 ag/mL) and remarkable selectivity in detecting CC chemokine ligand 2 (CCL2) protein biomarkers, outperforming conventional techniques such as ELISA. This work represents a breakthrough in traditional protein sensors, providing a direction and materials foundation for developing ultrasensitive sensors tailored to clinical applications for biomarker sensing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesBiosensing TechniquesChemokine CCL2BiomarkersHumansLimit of DetectionElectrochemical Techniques

Stichwörter der Autor:innen

CCL2WS2charge-sensitivediabetic nephropathyplasmonic electrochemical impedance microscopy

Substanzen

Chemokine CCL2BiomarkersCCL2 protein, human

Autor:innen und Institutionen

  • Center for High Pressure Science, State Key Lab of Metastable Materials Science and Technology, Yanshan University, Qinhuangdao 066004, China.
  • Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao 066000, China.
  • Institute of Quantum Materials and Devices, School of Electronics and Information Engineering, Tiangong University, Tianjin 300387, China.

ORCID-Profile: Fusheng Wen, Jianyong Xiang, Kun Zhai, Congpu Mu, Tianyu Xue

Förderung

  • National Key Research and Development Program of China
  • Department of Education of Hebei Province
  • National Natural Science Foundation of China
  • Medical Science Research Project of Hebei Province
  • 100 Talents Project of Hebei Province

Zitieren

APA

Gao, S., Li, H., Liu, L., Tian, Y., Wang, R., Pan, X., Wen, F., Xiang, J., Nie, A., Zhai, K., Wang, B., Mu, C., Xue, T., & Liu, Z. (2024). Ultrasensitive CCL2 Detection in Urine for Diabetic Nephropathy Diagnosis Using a WS 2 -Based Plasmonic Biosensor. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c00981

Vancouver

Gao S, Li H, Liu L, Tian Y, Wang R, Pan X, et al. Ultrasensitive CCL2 Detection in Urine for Diabetic Nephropathy Diagnosis Using a WS 2 -Based Plasmonic Biosensor. Nano Letters. 2024. doi:10.1021/acs.nanolett.4c00981

BibTeX
@article{Gao2024,
  author = {Gao, Shuangshuang and Li, Huili and Liu, Lixuan and Tian, Yiming and Wang, Rui and Pan, Xuanlin and Wen, Fusheng and Xiang, Jianyong and Nie, Anmin and Zhai, Kun and Wang, Bochong and Mu, Congpu and Xue, Tianyu and Liu, Zhongyuan},
  title = {Ultrasensitive CCL2 Detection in Urine for Diabetic Nephropathy Diagnosis Using a WS 2 -Based Plasmonic Biosensor},
  journal = {Nano Letters},
  year = {2024},
  doi = {10.1021/acs.nanolett.4c00981}
}
Kostenlos starten →